Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1988 Aug;56(8):2163–2168. doi: 10.1128/iai.56.8.2163-2168.1988

Clearance of different strains of Mycoplasma pulmonis from the respiratory tract of C3H/HeN mice.

M K Davidson 1, J K Davis 1, J R Lindsey 1, G H Cassell 1
PMCID: PMC259539  PMID: 3397188

Abstract

Pathogen-free C3H/HeN mice were exposed by aerosol to Mycoplasma pulmonis PG34(ASH), UAB 5782C, M1, UAB T, or UAB CT, and clearance of mycoplasmas from the nasal passages, trachea, and lungs was determined during the first 72 h postinoculation (PI). There were differences among strains of mycoplasmas in physical removal of organisms and in killing by nonspecific factors in the nasal passages and trachea. The avirulent strain, PG34(ASH), was quickly removed from the nasal passages and trachea. Physical removal of the other mycoplasmal strains occurred slowly, with 60 to 89% of the radioactive label remaining in the nasal passages and trachea even after 72 h. There were significant differences in killing among mycoplasmal strains by nonspecific host mechanisms in the nasal passages, trachea, and lungs. Strain UAB T was quickly killed at all levels of the respiratory tract. Strains UAB 5782C and M1 were killed at all three sites by 2 to 4 h PI. The most virulent strain, UAB CT, was killed much more slowly than the other strains. However, there was no statistical difference in the relative numbers of mycoplasmas present in the lungs at 72 h PI among strains UAB CT, UAB 5782C, and M1. These studies showed that the different mycoplasmal strains were cleared from the respiratory tract by different mechanisms and suggest that the differences in virulence among the mycoplasma strains can be explained, in part, by the differences in elimination of the organisms from the respiratory tract by nonspecific host defense mechanisms.

Full text

PDF
2163

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baseman J. B., Cole R. M., Krause D. C., Leith D. K. Molecular basis for cytadsorption of Mycoplasma pneumoniae. J Bacteriol. 1982 Sep;151(3):1514–1522. doi: 10.1128/jb.151.3.1514-1522.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bianco A., Bassi P., Belvisi M., Tarroni G. Inhalation of a radioactively labeled monodisperse aerosol in rats for the assessment of regional deposition and clearance. Am Ind Hyg Assoc J. 1980 Aug;41(8):563–567. doi: 10.1080/15298668091425284. [DOI] [PubMed] [Google Scholar]
  3. Cassell G. H. Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model. Rev Infect Dis. 1982 May-Jun;4 (Suppl):S18–S34. doi: 10.1093/clinids/4.supplement_1.s18. [DOI] [PubMed] [Google Scholar]
  4. Davidson M. K., Lindsey J. R., Parker R. F., Tully J. G., Cassell G. H. Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect Immun. 1988 Aug;56(8):2156–2162. doi: 10.1128/iai.56.8.2156-2162.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis J. K., Parker R. F., White H., Dziedzic D., Taylor G., Davidson M. K., Cox N. R., Cassell G. H. Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice. Infect Immun. 1985 Dec;50(3):647–654. doi: 10.1128/iai.50.3.647-654.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davis J. K., Thorp R. B., Parker R. F., White H., Dziedzic D., D'Arcy J., Cassell G. H. Development of an aerosol model of murine respiratory mycoplasmosis in mice. Infect Immun. 1986 Oct;54(1):194–201. doi: 10.1128/iai.54.1.194-201.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davis J., Cassell G. H., Gambill G., Cox N., Watson H., Davidson M. Diagnosis of murine mycoplasmal infections by enzyme-linked immunosorbent assay (ELISA). Isr J Med Sci. 1987 Jun;23(6):717–722. [PubMed] [Google Scholar]
  8. GREEN G. M., KASS E. H. THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG. J Exp Med. 1964 Jan 1;119:167–176. doi: 10.1084/jem.119.1.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gourlay R. N., Howard C. J. Respiratory mycoplasmosis. Adv Vet Sci Comp Med. 1982;26:289–332. [PubMed] [Google Scholar]
  10. Green G. M., Goldstein E. A method for quantitating intrapulmonary bacterial inactivation in individual animals. J Lab Clin Med. 1966 Oct;68(4):669–677. [PubMed] [Google Scholar]
  11. Horowitz S. A., Cassell G. H. Detection of antibodies to Mycoplasma pulmonis by an enzyme-linked immunosorbent assay. Infect Immun. 1978 Oct;22(1):161–170. doi: 10.1128/iai.22.1.161-170.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Howard C. J., Taylor G. Variation in the virulence of strains of Mycoplasma pulmonis related to susceptibility to killing by macrophages in vivo. J Gen Microbiol. 1979 Oct;114(2):289–294. doi: 10.1099/00221287-114-2-289. [DOI] [PubMed] [Google Scholar]
  13. Jones T. C., Yeh S., Hirsch J. G. Studies on attachment and ingestion phases of phagocytosis of Mycoplasma pulmonis by mouse peritoneal macrophages. Proc Soc Exp Biol Med. 1972 Feb;139(2):464–470. doi: 10.3181/00379727-139-36165. [DOI] [PubMed] [Google Scholar]
  14. Juers J. A., Rogers R. M., McCurdy J. B., Cook W. W. Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material. J Clin Invest. 1976 Aug;58(2):271–275. doi: 10.1172/JCI108468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LaForce F. M. Effect of alveolar lining material on phagocytic and bactericidal activity of lung macrophages against Staphylococcus aureau. J Lab Clin Med. 1976 Nov;88(5):691–699. [PubMed] [Google Scholar]
  16. Lai W. C., Pakes S. P., Lu Y. S., Brayton C. F. Mycoplasma pulmonis infection augments natural killer cell activity in mice. Lab Anim Sci. 1987 Jun;37(3):299–303. [PubMed] [Google Scholar]
  17. Ortaldo J. R., Herberman R. B. Heterogeneity of natural killer cells. Annu Rev Immunol. 1984;2:359–394. doi: 10.1146/annurev.iy.02.040184.002043. [DOI] [PubMed] [Google Scholar]
  18. Parker R. F., Davis J. K., Blalock D. K., Thorp R. B., Simecka J. W., Cassell G. H. Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice. Infect Immun. 1987 Nov;55(11):2631–2635. doi: 10.1128/iai.55.11.2631-2635.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schoeb T. R., Davidson M. K., Lindsey J. R. Intracage ammonia promotes growth of Mycoplasma pulmonis in the respiratory tract of rats. Infect Immun. 1982 Oct;38(1):212–217. doi: 10.1128/iai.38.1.212-217.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Taylor G., Howard C. J. Interaction of Mycoplasma pulmonis with mouse peritoneal macrophages and polymorphonuclear leucocytes. J Med Microbiol. 1980 Feb;13(1):19–30. doi: 10.1099/00222615-13-1-19. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES